Literature DB >> 19041276

Interferon gamma: a master regulator of atherosclerosis.

James E McLaren1, Dipak P Ramji.   

Abstract

Atherosclerosis is a chronic inflammatory disease that is characterized by the development of fibrotic plaques in the arterial wall. The disease exhibits a complex aetiology and its progression is influenced by a number of environmental and genetic risk factors. The cytokine interferon-gamma (IFN-gamma), a key regulator of immune function, is highly expressed in atherosclerotic lesions and has emerged as a significant factor in atherogenesis. Evidence from both mouse models of atherosclerosis and in vitro cell culture has suggested that the role of IFN-gamma is complex since both pro- and anti-atherogenic actions have been affiliated to it. This review will focus on evaluating the contribution of IFN-gamma to atherosclerosis and, in particular, how it regulates immune responses to the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041276     DOI: 10.1016/j.cytogfr.2008.11.003

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  92 in total

1.  Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Ernesto L Schiffrin; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

Review 2.  Liver X receptors, atherosclerosis and inflammation.

Authors:  Daryn R Michael; Tim G Ashlin; Melanie L Buckley; Dipak P Ramji
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

3.  Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis.

Authors:  Joshua Abd Alla; Andreas Langer; Sherif S Elzahwy; Gökhan Arman-Kalcek; Thomas Streichert; Ursula Quitterer
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

4.  Understanding gene expression in coronary artery disease through global profiling, network analysis and independent validation of key candidate genes.

Authors:  Prathima Arvind; Shanker Jayashree; Srikarthika Jambunathan; Jiny Nair; Vijay V Kakkar
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

5.  Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke.

Authors:  Ying Bai; Shaofang Nie; Guiqing Jiang; Yingchao Zhou; Mengchen Zhou; Yuanyuan Zhao; Sisi Li; Fan Wang; Qiulun Lv; Yufeng Huang; Qin Yang; Qingxian Li; Yue Li; Yunlong Xia; Ying Liu; Jinqiu Liu; Jin Qian; Bin Li; Gang Wu; Yanxia Wu; Binbin Wang; Xiang Cheng; Yanzong Yang; Tie Ke; Hui Li; Xiang Ren; Xu Ma; Yuhua Liao; Chengqi Xu; Xin Tu; Qing K Wang
Journal:  Stroke       Date:  2014-01-02       Impact factor: 7.914

6.  STAT4 deficiency reduces the development of atherosclerosis in mice.

Authors:  Parésa L Taghavie-Moghadam; Breanne N Gjurich; Rukhsana Jabeen; Purna Krishnamurthy; Mark H Kaplan; Anca D Dobrian; Jerry L Nadler; Elena V Galkina
Journal:  Atherosclerosis       Date:  2015-09-04       Impact factor: 5.162

Review 7.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

Review 8.  Inflammation and immune system interactions in atherosclerosis.

Authors:  Bart Legein; Lieve Temmerman; Erik A L Biessen; Esther Lutgens
Journal:  Cell Mol Life Sci       Date:  2013-02-21       Impact factor: 9.261

Review 9.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

10.  The relationship between brachial ankle pulse wave velocity and complement 1 inhibitor.

Authors:  Yong Min Chae; Jong Kwon Park
Journal:  J Korean Med Sci       Date:  2009-09-23       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.